Innovative Approaches to Increase Access to Medicines in Developing Countries

Access to essential medicines is problematic for one third of all persons worldwide. The price of many medicines (i.e., drugs, vaccines, and diagnostics) is unaffordable to the majority of the population in need, especially in least-developed countries, but also increasingly in middle-income countri...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in medicine Vol. 4; p. 218
Main Authors Stevens, Hilde, Huys, Isabelle
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Access to essential medicines is problematic for one third of all persons worldwide. The price of many medicines (i.e., drugs, vaccines, and diagnostics) is unaffordable to the majority of the population in need, especially in least-developed countries, but also increasingly in middle-income countries. Several innovative approaches, based on partnerships, intellectual property, and pricing, are used to stimulate innovation, promote healthcare delivery, and reduce global health disparities. No single approach suffices, and therefore stakeholders need to further engage in partnerships promoting knowledge and technology transfer in assuring essential medicines to be manufactured, authorized, and distributed in low- and middle-income countries (LMICs) in an effort of making them available at affordable and acceptable conditions.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Specialty section: This article was submitted to Regulatory Science, a section of the journal Frontiers in Medicine
Reviewed by: Sarah Galbraith-Emami, World Health Organization, United States; M. Rashad Massoud, University Research Co, United States
Edited by: Sandor Kerpel-Fronius, Semmelweis University, Hungary
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2017.00218